Title

Tumor Suppression by Phospholipase C-beta3 via SHP-1-mediated Dephosphorylation of Stat5

Document Type

Article

Publication Date

8-4-2009

Journal

Cancer Cell

Volume

16

Issue

2

First Page

161

Last Page

171

Abstract

Given its catalytic activity to generate diacylglycerol and inositol 1,4,5-trisphosphate, phospholipase C (PLC) is implicated in promoting cell growth. However, we found that PLC-beta3-deficient mice develop myeloproliferative disease, lymphoma, and other tumors. The mutant mice have increased numbers of hematopoietic stem cells with increased proliferative, survival, and myeloid-differentiative abilities. These properties are dependent on Stat5 and can be antagonized by the protein phosphatase SHP-1. Stat5-dependent cooperative transformation by active c-Myc and PLC-beta3 deficiency was suggested in mouse lymphomas in PLC-beta3(-/-) and in Emicro-myc;PLC-beta3(+/-) mice and human Burkitt's lymphoma cells. The same mechanism for malignant transformation seems to be operative in other human lymphoid and myeloid malignancies. Thus, PLC-beta3 is likely a tumor suppressor.

Notes

Published in: Cancer Cell, Volume 16, Issue 2, 161-171, 4 August 2009. doi: 10.1016/j.ccr.2009.05.018